Retatrutide and Other Metabolic Research Peptides Researchers frequently compare retatrutide with compounds such as: Tirzepatide Liraglutide GLP-1 receptor agonists Novel triple glucagon-like receptor agonists Published metabolic research by investigators including Jastreboff, Fras JP, Sanyal, Coskun, Urva, Roell WC, and Kaplan LM continues expanding interest in receptor agonist retatrutide for metabolic dysfunction-associated research
Patients report a reduced desire to eat highly seasoned and salty foods, or foods rich in carbohydrates, as well as a better ability to resist urges
The company also makes Victoza (liraglutide), another GLP-1
Cardiovascular Benefits Type 2 diabetes is often associated with an increased risk of cardiovascular diseases, including heart attack, stroke, and heart failure
Discuss with your healthcare provider to determine which medication is best for you
See which platform fits